Oral supplementation of FA ameliorates HCHF-induced MS, improves insulin sensitivity, lipid profiles and vascular endothelial function, decreases blood pressure, and reduces oxidative stress and inflammation. This evidence concerns the gene INS and myeloid sarcoma.